Literature DB >> 9330601

Retroviral introduction of the p16 gene into murine cell lines to elicit marked antiproliferative effects.

H Ikeda1, J Yoshida, H Yamada, T Yoshimatsu, K Ikenaka.   

Abstract

The p16 gene is a candidate tumor suppressor, because mutation of the gene has been reported in many transformed cell lines and some primary tumor tissues. We have examined this possibility in murine cell lines (NIH3T3 and RSV-M) which lack p16 gene expression. Full-length human p16 cDNA was obtained from a HeLa cell line using polymerase chain reaction amplification. We constructed two separate retrovirus vectors carrying this p16 cDNA. First, we transduced the p16 cDNA into the murine cell lines using a retrovirus vector harboring the neomycin-resistance gene. The p16 gene-transduced cells formed no colonies after selection with G418, in contrast to the vector-transduced cells. Next, we used another retrovirus vector that expresses both the p16 cDNA and the Lac Z gene, which enabled us to distinguish affected cells from unaffected ones. Proliferation of the p16 gene-transduced cells was markedly inhibited and morphological change in the cells was also observed. Thus, we concluded that the p16 gene has an antiproliferative effect on the cell cycle and that the loss of its function may play a major role in dysregulated proliferation of the cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9330601      PMCID: PMC5921492          DOI: 10.1111/j.1349-7006.1997.tb00441.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  36 in total

1.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

2.  Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors.

Authors:  I Orlow; P Lianes; L Lacombe; G Dalbagni; V E Reuter; C Cordon-Cardo
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

3.  Inhibition of ras-induced proliferation and cellular transformation by p16INK4.

Authors:  M Serrano; E Gómez-Lahoz; R A DePinho; D Beach; D Bar-Sagi
Journal:  Science       Date:  1995-01-13       Impact factor: 47.728

4.  Deletions and rearrangements inactivate the p16INK4 gene in human glioma cells.

Authors:  K S Srivenugopal; F Ali-Osman
Journal:  Oncogene       Date:  1996-05-02       Impact factor: 9.867

5.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

Authors:  J G Herman; A Merlo; L Mao; R G Lapidus; J P Issa; N E Davidson; D Sidransky; S B Baylin
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

6.  The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos.

Authors:  I R Ghattas; J R Sanes; J E Majors
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

7.  Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells.

Authors:  J Fueyo; C Gomez-Manzano; W K Yung; G L Clayman; T J Liu; J Bruner; V A Levin; A P Kyritsis
Journal:  Oncogene       Date:  1996-01-04       Impact factor: 9.867

8.  Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.

Authors:  T Mori; K Miura; T Aoki; T Nishihira; S Mori; Y Nakamura
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

9.  Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4.

Authors:  F K Chan; J Zhang; L Cheng; D N Shapiro; A Winoto
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

10.  Expression of proteolipid protein gene is directly associated with secretion of a factor influencing oligodendrocyte development.

Authors:  J Nakao; M Yamada; T Kagawa; S U Kim; Y Miyao; K Shimizu; K Mikoshiba; K Ikenaka
Journal:  J Neurochem       Date:  1995-06       Impact factor: 5.372

View more
  1 in total

1.  Mutant Plp/DM20 cannot be processed to secrete PLP-related oligodendrocyte differentiation/survival factor.

Authors:  M Yamada; M Jung; K Tetsushi; A Ivanova; K A Nave; K Ikenaka
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.